Hot Products

Hot products from BioCrick which is a professional high-purity natural products manufacturer are well known to scientists around the world because of their high purity and stability. Each product is a chemical compound or substance produced by a living organism—that is, found in nature. In the broadest sense, natural products include any substance produced by life.Natural products remain the best sources of drugs and drug leads, and this remains true today despite the fact that many pharmaceutical companies have deemphasized natural products research in favor of HTP screening of combinatorial libraries during the past 2 decades. From 1940s to date, 131 (74.8%) out of 175 small molecule anticancer drugs are natural product-based/inspired, with 85 (48.6%) being either natural products or derived therefrom. From 1981 to date, 79 (80%) out of 99 small molecule anticancer drugs are natural product-based/inspired, with 53 (53%) being either natural products or derived therefrom. Among the 20 approved small molecule New Chemical Entities (NCEs) in 2010, a half of them are natural products.

Hot products from the professional high-purity natural products manufacturer

Cat.No. Product Name
BCN4085 Magnolignan C
Magnolignan C is a natural product from Magnolia officinalis.
BCN4516 Maoecrystal B
Standard reference
BCN3283 Maoyecrystal E
Maoyecrystal E is a natural product from Isodon japonicus.
BCN3944 Maoyerabdosin
Standard reference
BCN4564 Marsdenoside F
Marsdenoside F is a natural product from Marsdenia tenacissima.
BCN4511 Massoniresinol
Standard reference
BCN2848 Matairesinol 4'-O-beta-gentiobioside
Matairesinol 4'-O-beta-gentiobioside is a natural product from Trachelospermum jasminoides.
BCN5789 Matairesinol
Matairesinol has radical and superoxide scavenging activities,; it also has anti-angiogenic activity by suppressing mROS signaling , can decrease hypoxia-inducible factor-1α in hypoxic HeLa cells.Matairesinol has anti-osteoporotic activity via p38/ERK-NFATc1 signaling, but not by way of anti-resorptive action. Matairesinol could markedly benefit TRAIL-based tumor therapies, including those aimed at prostate cancer.